drugset / Trial / NCT01664520
Dexmedetomidine and Subarachnoid Haemorrhage
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to investigate how dexmedetomidine affects static and dynamic autoregulation, intracranial pressure (ICP) and cerebral oxygenation in aneurysmal subarachnoid haemorrhage (SAH) patients.
Timeline
- Start
- 2013-06
- Primary completion
- 2016-11-30
- Completion
- 2016-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1.4 ug/kg | — |